Juan‐Cheng Yang

458 total citations
26 papers, 307 citations indexed

About

Juan‐Cheng Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Juan‐Cheng Yang has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Juan‐Cheng Yang's work include Cancer, Lipids, and Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Juan‐Cheng Yang is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Juan‐Cheng Yang collaborates with scholars based in Taiwan, China and Egypt. Juan‐Cheng Yang's co-authors include Yang‐Chang Wu, Wen‐Lung Ma, Wei‐Chung Cheng, Guanyu Chen, Chi‐Chen Fan, Wei‐Chun Chang, Wei‐Chao Chang, George T.Y. Chen, Wei‐Chien Huang and Pei-Chun Shen and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Juan‐Cheng Yang

25 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan‐Cheng Yang Taiwan 12 171 60 33 29 26 26 307
Yujuan Zhan China 12 274 1.6× 88 1.5× 45 1.4× 38 1.3× 39 1.5× 23 440
Lihui Si China 14 200 1.2× 119 2.0× 33 1.0× 19 0.7× 24 0.9× 26 434
Gunho Won South Korea 11 219 1.3× 80 1.3× 32 1.0× 27 0.9× 15 0.6× 16 345
Emilie Logie Belgium 11 153 0.9× 58 1.0× 22 0.7× 61 2.1× 18 0.7× 15 383
Saki Gotoh Japan 12 261 1.5× 61 1.0× 50 1.5× 19 0.7× 28 1.1× 18 429
Shi‐You Jiang China 8 194 1.1× 73 1.2× 39 1.2× 15 0.5× 32 1.2× 11 390
Genhai Shen China 10 202 1.2× 84 1.4× 58 1.8× 22 0.8× 24 0.9× 15 334
Mohamed Hessien Egypt 12 189 1.1× 44 0.7× 59 1.8× 41 1.4× 14 0.5× 31 361
Jia-Ni Lin Taiwan 9 262 1.5× 69 1.1× 45 1.4× 40 1.4× 32 1.2× 16 481
Pingcui Xu China 13 285 1.7× 77 1.3× 28 0.8× 64 2.2× 40 1.5× 21 448

Countries citing papers authored by Juan‐Cheng Yang

Since Specialization
Citations

This map shows the geographic impact of Juan‐Cheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan‐Cheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan‐Cheng Yang more than expected).

Fields of papers citing papers by Juan‐Cheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan‐Cheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan‐Cheng Yang. The network helps show where Juan‐Cheng Yang may publish in the future.

Co-authorship network of co-authors of Juan‐Cheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Juan‐Cheng Yang. A scholar is included among the top collaborators of Juan‐Cheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan‐Cheng Yang. Juan‐Cheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Su, Yu‐Ting, Wei‐Chun Chang, Lumin Chen, et al.. (2024). Ether‐Linked Glycerophospholipids Are Potential Chemo‐Desensitisers and Are Associated With Overall Survival in Carcinoma Patients. Journal of Cellular and Molecular Medicine. 28(24). e70277–e70277. 1 indexed citations
3.
Huang, Yukai, Wei‐Chung Cheng, Juan‐Cheng Yang, et al.. (2024). Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature Cancer. 5(3). 400–419. 14 indexed citations
4.
5.
Chu, Pei‐Yi, Yingchun Yu, Juan‐Cheng Yang, et al.. (2024). Effects of Citrus depressa Hayata juice on high-fat diet-induced obesity in HBV transgenic mice. Heliyon. 10(2). e24438–e24438. 1 indexed citations
6.
Chu, Pei‐Yi, Ching‐Chan Lin, Lie‐Fen Shyur, et al.. (2024). Glutathione S‐transferase omega class 1 (GSTO1)‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer. Molecular Oncology. 18(8). 1866–1884. 5 indexed citations
7.
Wu, Chieh‐Hsin, Jen‐Huai Chiang, Yung‐Hsiang Chen, et al.. (2023). The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients. Cancers. 15(4). 1213–1213. 5 indexed citations
8.
Ma, Wen‐Lung, Ning Chang, Yingchun Yu, et al.. (2022). Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growth. Cancer Medicine. 11(14). 2824–2835. 18 indexed citations
9.
Chu, Pei‐Yi, Guanyu Chen, Ke Wang, et al.. (2022). Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin–DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model. International Journal of Molecular Sciences. 23(3). 1868–1868. 5 indexed citations
10.
Huang, Chieh-Liang, Yao‐Chang Chiang, Juan‐Cheng Yang, et al.. (2021). Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment. Frontiers in Endocrinology. 12. 638884–638884. 1 indexed citations
11.
Wang, Ke, Juan‐Cheng Yang, Yeong‐Jiunn Jang, et al.. (2021). 19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), an ent-abietane diterpene diepoxide, inhibits the growth of bladder cancer T24 cells through DNA damage. PLoS ONE. 16(3). e0248468–e0248468. 4 indexed citations
12.
Chen, Guanyu, Tung‐Ying Wu, Wei‐Jan Wang, et al.. (2021). Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay. Journal of Traditional and Complementary Medicine. 12(1). 73–89. 15 indexed citations
13.
Shen, Pei-Chun, et al.. (2021). LipidSig: a web-based tool for lipidomic data analysis. Nucleic Acids Research. 49(W1). W336–W345. 45 indexed citations
14.
Chen, Guanyu, et al.. (2021). Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer. In Vivo. 35(2). 761–777. 7 indexed citations
15.
Fan, Chi‐Chen, Chen‐Yuan Lin, Ling‐Chu Chang, et al.. (2020). EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. Redox Biology. 34. 101571–101571. 42 indexed citations
16.
Chen, Lumin, Wen‐Lung Ma, Wei‐Chung Cheng, et al.. (2020). Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy. Journal of Cellular and Molecular Medicine. 24(13). 7187–7200. 11 indexed citations
17.
Chiang, Hsiu‐Mei, et al.. (2018). New diterpenes leojaponins G–L from Leonurus japonicus. Fitoterapia. 130. 125–133. 12 indexed citations
18.
Cheng, Bi‐Hua, Wei‐Chun Chang, Hsueh‐Chou Lai, et al.. (2018). Survival benefit of sphingosin‐1‐phosphate and receptors expressions in breast cancer patients. Cancer Medicine. 7(8). 3743–3754. 13 indexed citations
19.
Lai, Kuei-Hung, Mei‐Chin Lu, Mohamed El‐Shazly, et al.. (2016). Cytotoxic Lanostanoids from Poria cocos. Journal of Natural Products. 79(11). 2805–2813. 36 indexed citations
20.
Zhang, Dayong, Jinhui Wu, Ke Wang, et al.. (2016). Synthesis of Novel 3,19-Dihydroxyjolkinolides and Related Derivatives Starting from Andrographolide. Synthesis. 48(14). 2245–2254. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yujuan Zhan Breakdown of academic impact, for papers by Lihui Si Breakdown of academic impact, for papers by Gunho Won Breakdown of academic impact, for papers by Emilie Logie Breakdown of academic impact, for papers by Saki Gotoh Breakdown of academic impact, for papers by Shi‐You Jiang Breakdown of academic impact, for papers by Genhai Shen Breakdown of academic impact, for papers by Mohamed Hessien Breakdown of academic impact, for papers by Jia-Ni Lin Breakdown of academic impact, for papers by Pingcui Xu
Rankless by CCL
2026